Education
About Us
Working with TipRanks
Follow Us
Jyong Biotech Ltd. (MENS)
:MENS
MENS Stock Chart & Stats
$59.00
--
Market closed
$59.00
--
Day’s Range― - ―
52-Week Range$6.01 - $67.00
Previous CloseN/A
VolumeN/A
Average Volume (3M)419.84K
Market Cap
N/A
Enterprise ValueN/A
Total Cash (Recent Filing)$98.00K
Total Debt (Recent Filing)$18.14M
Price to Earnings (P/E)―
Beta2.88
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding76,027,664
10 Day Avg. Volume464,188
30 Day Avg. Volume419,841
Financial Highlights & Ratios
PEG Ratio8.10
Price to Book (P/B)-21.05
Price to Sales (P/S)0.00
P/FCF Ratio-212.10
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit0.00
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
MENS FAQ
What was Jyong Biotech Ltd.’s price range in the past 12 months?
Jyong Biotech Ltd. lowest stock price was $6.01 and its highest was $67.00 in the past 12 months.
What is Jyong Biotech Ltd.’s market cap?
Currently, no data Available
When is Jyong Biotech Ltd.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Jyong Biotech Ltd.’s earnings last quarter?
Currently, no data Available
Is Jyong Biotech Ltd. overvalued?
According to Wall Street analysts Jyong Biotech Ltd.’s price is currently Overvalued.
Does Jyong Biotech Ltd. pay dividends?
Jyong Biotech Ltd. does not currently pay dividends.
What is Jyong Biotech Ltd.’s EPS estimate?
Jyong Biotech Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Jyong Biotech Ltd. have?
Jyong Biotech Ltd. has 76,027,664 shares outstanding.
What happened to Jyong Biotech Ltd.’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Jyong Biotech Ltd.?
Currently, no hedge funds are holding shares in MENS
Company Description
Jyong Biotech Ltd.
Jyong Biotech Ltd. is a Taiwan-based biotech firm focused on developing and commercializing plant-derived drugs targeting urinary system diseases. The company operates through its subsidiaries—Health Ever Bio-Tech, Genvace, and others—working on drug candidates like MCS‑2 (for BPH) currently in Phase III, PCP (for prostate cancer) in Phase II, and IC in pre-clinical stages
Technical Analysis
AIM ImmunoTech
―
Biodexa Pharmaceuticals
―
Nucana
―
Lixte Biotechnology Holdings
―
Galecto
―
Ownership Overview
―
Insiders
― Other Institutional Investors
99.98% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---